Abstract:BackgroundSince China has a unique system of delivering HIV care that includes all patients' records. The factors related to CD4+ T-cell recovery and viral suppression in patients who have low CD4+ T cell counts at the initiation of HAART are understudied in the China despite subsequent virological suppression (viral load < 50 copies/mL) is unknown.MethodsThe authors conducted a retrospective cohort study using data from the national HIV treatment sub-database of Zhejiang province to identify records of HIV+ patients. Patient records were included if they were < 16 years of age, had an initial CD4 count < 100 cells/mu L, were on continuous HAART for at least one year by the end of December 31, 2014; and achieved and maintained continued maximum virological suppression (MVS) (< 50 copies/ml) by 9 months after starting HAART. The primary endpoint for analysis was time to first CD4+ T cell count recovery (>= 200, 350, 500 cells/mu L). Cox proportional hazard regression was used to identify the risk factors for CD4+ T cell count recovery to key thresholds (200350, 350-500, >= 00 cells/mu L) by the time of last clinical follow-up (whichever occurred first), key thresholds (follow-up date for analysis), with patients still unable to reach the end-points being censored by the end December 31, 2014 (follow-up date for analysis).ResultsOf the 918 patients who were included in the study, and the median CD4+ T cell count was 39 cells/mu L at the baseline. At the end of follow-up, 727 (79.2%), 363 (39.5%) and 149 (16.2%) patients had return to >= 200, 350, and 500 cells/mu L, respectively. Kaplan-Meier analysis demonstrated that the rate of patients with CD4+ count recovery to >= 200, 350, and 500 cells/mu L after 1 year on HAART was 43.6, 8.6, and 2.5%, respectively, after 3 years on treatment was 90.8, 46.3, and 17.9%, respectively, and after 5 years on HAART was 97.1, 72.2, and 36.4%, respectively. The median time to return to 200-350, 350-500, >= 500cells/mu L was 1.11, 3.33 and 6.91 years, respectively. Factors of age (aHR = 0.77, 95% CI 0.61-0.97), baseline CD4+ count (aHR = 1.60, 95% CI 1.37-1.86), initial regimens, changes in regimen (aHR = 0.58, 95% CI 0.49-0.69), and inclusion of a cotrimoxazole prophylaxis (aHR = 0.66, 95% CI 0.51-0.85) were associated with CD4+ T cell count recovery.ConclusionThe proportion of patients with initially low CD4 counts after nine months of treatment and that achieved continuous virological suppression was greater than 70% for persons with CD4+ count >= 350. Conversely, only 35% of patients recovered to levels of 500 cells/mu L after 5 years of treatment, and levels continued to rise significantly with further long-term HAART. Early HAART intervention will be necessary for achieving effective CD4+ T cell responses and optimal immunological function in HIV+ patients.

[Survival Analysis of 530 HIV Infected Former Unsafe Commercial Blood and Plasma Donors].

A Retrospective Cohort Study on the Natural History of Human Immunodeficiency Virus among Formal Plasma Donors in Central China

Hiv-Infected Former Plasma Donors In Rural Central China: From Infection To Survival Outcomes, 1985-2008

Epidemiology, Clinical and Laboratory Characteristics of Currently Alive HIV-1 Infected Former Blood Donors Naive to Antiretroviral Therapy in Anhui Province, China

[The Median Survival and the Effect of Antiretroviral Therapy among HIV-positive Former Blood Donors in Anhui Province].

Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors

[The Epidemiological Study on Human Immunodeficiency Virus Infection among Paid Blood Donors Living in Shandong Provincial China Comprehensive Response Project Areas].

Survival Analysis of Antiretroviral Treatment for PLWH in Sichuan Province, China, 2003-2022: A Large Retrospective Cohort Study

Survival and Related Factors of 1 177 HIV/AIDS Patients with Antiretroviral Therapy in Beijing

HIV Cause-Specific Deaths, Mortality, Risk Factors, and the Combined Influence of HAART and Late Diagnosis in Zhejiang, China, 2006–2013

Epidemiologic Study on Human Immunodeficiency Virus Infection among Children in a Former Paid Plasma Donating Community in China

Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012

Effects of HIV Infection on Prognosis of HCV Infected Former Blood Donors

The Factors Related To Cd4+T-Cell Recovery And Viral Suppression In Patients Who Have Low Cd4+T Cell Counts At The Initiation Of Haart: A Retrospective Study Of The National Hiv Treatment Sub-Database Of Zhejiang Province, China, 2014

High-risk Sexual Behavior among HIV-positive Former Commercial Blood Donors in Rural Eastern and Central China

The survival analysis on antiretroviral therapy cas es of acquired immune deficiency syndrome based on time-dependent Cox regression model

Impact of Blood Bank Management and Blood Component on HIV Infection among Paid Blood Donors

Analysis of Liver-Related Mortality among Human Immunodeficiency Virus Infected Patients after Blood Donation Who Received Combined Antiretroviral Therapy

[Survival Status and Influencing Factors of HIV/AIDS on Highly Active Anti-Retrovial Therapy in Shandong Province].

Prevalence, incidence, and residual risk for human immunodeficiency virus among blood donors from 2003 to 2022 in Guangzhou, China

Correlation between clinical manifestations and disease progression among HIV-1 infected former blood donors in Anhui,China